ライフサイエンスコーパス: IUD

1 IUDs are now considered by many experts as a first-line

2 s (subdermal implant, 45% to 78% [P < .001]; IUD, 61% to 83% [P < .001]; injection, 28% to 44% [P = .

3 bout 1 h before insertion of a Copper T 380A IUD.

4 During the 90 days after IUD insertion, only one woman from each assignment group

5 was the rate of IUD expulsion 6 months after IUD insertion; an expulsion rate 8 percentage points hig

6 -genital-tract infection is negligible after IUD insertion, with or without the administration of pro

7 at 5 to 12 weeks of gestation who desired an IUD.

8 118 women did not have an IUD inserted.

9 gonorrhoea or chlamydial infection having an IUD inserted have a higher risk of salpingitis than do u

10 ilar to that of infected women not having an IUD inserted.

11 lpingitis than do uninfected women having an IUD inserted; however, the risk appears similar to that

12 The 6-month rate of expulsion of an IUD after immediate insertion was higher than but not in

13 The primary outcome was selection of an IUD or implant at the clinic visit and secondary outcome

14 ng 575 women who underwent randomization, an IUD was inserted in 100% (258 of 258) of the women in th

15 (P=0.07), all in women who never received an IUD.

16 ants using DMPA injection and those using an IUD or implant, regardless of age.

17 ine aspiration on rates of complications and IUD use are uncertain.

18 rates among users of subdermal implants and IUDs, as well as varying pregnancy and continuation rate

19 ow to counsel adolescents about implants and IUDs.

20 c review I summarise the evidence concerning IUD-associated infection and infertility.

21 Contemporary IUDs rival tubal sterilisation in efficacy and are much

22 ciation between the previous use of a copper IUD and tubal occlusion.

23 The previous use of a copper IUD is not associated with an increased risk of tubal oc

24 t study of HIV-positive women using a copper IUD suggests that there is no significant increase in th

25 associated with the previous use of a copper IUD was 1.0 (95 percent confidence interval, 0.6 to 1.7)

26 past use of contraceptives, including copper IUDs, previous sexual relationships, and history of geni

27 ver, the effects of immediate versus delayed IUD insertion after uterine aspiration on rates of compl

28 ard of an intrauterine contraceptive device (IUD).

29 before insertion of an intrauterine device (IUD) remains uncertain.

30 methods, which include intrauterine devices (IUDs) and subdermal hormonal implants, are used by only

31 eptive methods include intrauterine devices (IUDs) and subdermal implants and show great promise for

32 raceptive implants and intrauterine devices (IUDs) are long-acting reversible contraceptives (LARCs)

33 w discusses the use of intrauterine devices (IUDs) in United States teens as a potential strategy to

34 t infection related to intrauterine devices (IUDs) limits their wider use.

35 lling and insertion of intrauterine devices (IUDs) or progestin implants and 20 to provide standard c

36 Intrauterine devices (IUDs) provide highly effective, reversible, long-term co

37 Previous studies of intrauterine devices (IUDs), many of which are no longer in use, suggested tha

38 ersible contraception (intrauterine devices [IUDs] and implants) with other commonly prescribed contr

39 the likelihood that a woman would retain her IUD at 90 days or the frequency of postinsertion medical

40 rison group, overdiagnosis of salpingitis in IUD users, and inability to control for the confounding

41 LNG-IUD and, to a lesser extent, DMPA use were associated wi

42 5 expression were observed with DMPA and LNG-IUD use (P < .01 for all comparisons).

43 orgestrel-releasing intrauterine device (LNG-IUD; n = 27), oral contraceptive pills (n = 32), or no h

44 The use of LNG-IUD increased the proportion of CD4(+) and CD8(+) T cell

45 orgestrel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; n

46 cts an understanding of the safety of modern IUDs, the potential for this highly effective method to

47 orical concerns regarding the association of IUD and infection; however, modern studies have shown th

48 lity was not associated with the duration of IUD use, the reason for the removal of the IUD, or the p

49 ir evidence indicates no important effect of IUD use on tubal infertility.

50 The primary outcome was the rate of IUD expulsion 6 months after IUD insertion; an expulsion

51 The rate of IUD removal for any reason other than partial expulsion

52 whether such prophylaxis reduces the rate of IUD removal within 90 days.

53 ediate insertion resulted in higher rates of IUD use at 6 months, without an increased risk of compli

54 Six-month rates of IUD use were higher in the immediate-insertion group (92

55 y, eliminate user error, and, in the case of IUDs, have extremely low or no systemic drug absorption.

56 trol sites reported receiving counselling on IUDs or implants (565 [71%] of 797 vs 271 [39%] of 693,

57 Recently, IUDs have become a recommended contraceptive option for

58 hern California enrolled women who requested IUD insertion and were at low risk of sexually transmitt

59 The concern that IUDs that contain copper--currently the most commonly us

60 Current data do not support that IUDs affect long-term fertility or increase sexually tra

61 f IUD use, the reason for the removal of the IUD, or the presence or absence of gynecologic problems

62 Traditionally, the IUD was not thought of as an appropriate teen contracept

63 s were randomly assigned (in a 5:6 ratio) to IUD insertion immediately after the procedure or 2 to 6